Babur Betul Kul, Futrega Kathryn, Lott William B, Klein Travis Jacob, Cooper-White Justin, Doran Michael Robert
Stem Cell Therapies Laboratory, Institute of Health and Biomedical Innovation, Queensland University of Technology at the Translational Research Institute, Brisbane, Australia.
Cell Tissue Res. 2015 Sep;361(3):755-68. doi: 10.1007/s00441-015-2159-y. Epub 2015 Apr 30.
Engineered biphasic osteochondral tissues may have utility in cartilage defect repair. As bone-marrow-derived mesenchymal stem/stromal cells (MSC) have the capacity to make both bone-like and cartilage-like tissues, they are an ideal cell population for use in the manufacture of osteochondral tissues. Effective differentiation of MSC to bone-like and cartilage-like tissues requires two unique medium formulations and this presents a challenge both in achieving initial MSC differentiation and in maintaining tissue stability when the unified osteochondral tissue is subsequently cultured in a single medium formulation. In this proof-of-principle study, we used an in-house fabricated microwell platform to manufacture thousands of micropellets formed from 166 MSC each. We then characterized the development of bone-like and cartilage-like tissue formation in the micropellets maintained for 8-14 days in sequential combinations of osteogenic or chondrogenic induction medium. When bone-like or cartilage-like micropellets were induced for only 8 days, they displayed significant phenotypic changes when the osteogenic or chondrogenic induction medium, respectively, was swapped. Based on these data, we developed an extended 14-day protocol for the pre-culture of bone-like and cartilage-like micropellets in their respective induction medium. Unified osteochondral tissues were formed by layering 12,000 osteogenic micropellets and 12,000 chondrogenic micropellets into a biphasic structure and then further culture in chondrogenic induction medium. The assembled tissue was cultured for a further 8 days and characterized via histology. The micropellets had amalgamated into a continuous structure with distinctive bone-like and cartilage-like regions. This proof-of-concept study demonstrates the feasibility of micropellet assembly for the formation of osteochondral-like tissues for possible use in osteochondral defect repair.
工程化双相骨软骨组织可能在软骨缺损修复中具有应用价值。由于骨髓间充质干/基质细胞(MSC)具有形成骨样组织和软骨样组织的能力,它们是用于制造骨软骨组织的理想细胞群体。将MSC有效分化为骨样组织和软骨样组织需要两种独特的培养基配方,这在实现MSC初始分化以及随后在单一培养基配方中培养统一的骨软骨组织时维持组织稳定性方面都构成了挑战。在这项原理验证研究中,我们使用内部制造的微孔平台制造了数千个由166个MSC形成的微球。然后,我们对在成骨或软骨诱导培养基的连续组合中维持8 - 14天的微球中骨样组织和软骨样组织形成的发展进行了表征。当骨样或软骨样微球仅诱导8天时,分别更换成骨或软骨诱导培养基后,它们显示出显著的表型变化。基于这些数据,我们制定了一个延长至14天的方案,用于在各自的诱导培养基中对骨样和软骨样微球进行预培养。通过将12,000个成骨微球和12,000个软骨微球分层形成双相结构,然后在软骨诱导培养基中进一步培养,形成统一的骨软骨组织。组装后的组织再培养8天并通过组织学进行表征。微球已融合成具有独特骨样和软骨样区域的连续结构。这项概念验证研究证明了微球组装形成骨软骨样组织用于骨软骨缺损修复的可行性。